Sonnet BioTherapeutics, Inc. (NASDAQ:SONN) | WebDisclosure

Basculer en Français

11244	Companies
249556	Keywords
177656	Articles
135368	Press releases

Headlines Articles Press releases Sonnet BioTherapeutics, Inc.

Home
Companies
Sonnet BioTherapeutics, Inc.

PRESS RELEASE

published on 02/29/2024 at 22:05, 2 years 7 months ago

Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers
Sonnet BioTherapeutics Holdings, Inc. announced the publication of clinical data on SON-1010, a tumor-targeted immunotherapeutic drug combining FHAB construct with IL-12 in Frontiers in Immunology, showing favorable safety and tolerability

Clinical Data Sonnet BioTherapeutics SON-1010 Immunotherapeutic Drug FHAB Technology
PRESS RELEASE

published on 02/14/2024 at 13:30, 2 years 8 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
Sonnet BioTherapeutics Holdings, Inc. successfully raised $4.55 million, published preclinical data on SON-1210, executed NJ NOLs agreement, Phase 1b SON-080 trial enrollment completed, financial results announced for quarter ended Dec 31, 2023

Financial Results Preclinical Data Public Offering Sonnet BioTherapeutics Holdings NJ NOLs
PRESS RELEASE

published on 12/21/2023 at 14:00, 2 years 10 months ago

Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy
PRESS RELEASE

published on 12/14/2023 at 22:15, 2 years 10 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
PRESS RELEASE

published on 10/31/2023 at 12:30, 2 years 11 months ago

Sonnet BioTherapeutics Provides Fiscal Year 2023 Business Overview
PRESS RELEASE

published on 10/25/2023 at 13:30, 3 years ago

Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering
PRESS RELEASE

published on 10/17/2023 at 14:00, 3 years ago

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
PRESS RELEASE

published on 09/20/2023 at 13:30, 3 years 1 month ago

Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology

Accesswire

Published on 10/29/2026 at 07:30, 32 minutes ago

Tocvan Pilot Mine Trench at Gran Pilar Averages 4.6 g/t Au With Samples Up to 24.4 g/t Au; New Zone 1.3 km East Returns Up to 234 g/t Ag
Published on 10/28/2026 at 22:35, 9 hours 27 minutes ago

Route1 Announces Third Quarter and Year to Date 2026 Financial Results Notification
Published on 10/28/2026 at 12:30, 19 hours 32 minutes ago

Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 19 hours 32 minutes ago

AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 19 hours 32 minutes ago

Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out

View all ACCESSWIRE

EQS Group

Published on 10/29/2026 at 07:49, 12 minutes ago

Finexity AG: FINEXITY Group significantly ahead of budget after the first nine months of 2026
Published on 10/29/2026 at 07:45, 17 minutes ago

COP17 | Jiangsu Showcases Biodiversity Conservation in Action
Published on 10/29/2026 at 07:30, 32 minutes ago

Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026
Published on 10/29/2026 at 07:30, 32 minutes ago

Drägerwerk AG & Co. KGaA: Dräger with higher net sales and earnings in the first nine months of 2026
Published on 10/29/2026 at 07:30, 32 minutes ago

ANDRITZ achieves high order intake and strong revenue growth in Q3 2026

Les Echos

Published on 10/29/2026 at 07:20, 42 minutes ago

Q3 2026: Air Liquide accelerates, driven by sales growth and the launch of its strategic plan
Published on 10/29/2026 at 07:20, 42 minutes ago

T3 2026 : Air Liquide accélère, porté par des ventes en croissance et le lancement de son plan stratégique
Published on 10/29/2026 at 06:55, 1 hour 7 minutes ago

Recticel in hogere versnelling
Published on 10/29/2026 at 06:55, 1 hour 7 minutes ago

Recticel in higher gear
Published on 10/28/2026 at 18:09, 13 hours 52 minutes ago

Mandat de rachat d’actions

View all LES ECHOS COMFI WIRE